These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32619726)

  • 41. Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor.
    Chang WL; Yang WC; Zeng XY; Li CG; Xiong Z; Wang T; Zhang RZ; Tao KX; Zhang P
    BMC Gastroenterol; 2020 Apr; 20(1):124. PubMed ID: 32321434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Effective Predictors of Prognosis in Patients with Acute Mesenteric Arterial Embolism and Thrombosis.
    Wang S; Liu H; Wang Q; Cheng Z; Sun S; Zhang Y; Sun X; Wang Z; Ren L
    Ann Vasc Surg; 2018 May; 49():115-122. PubMed ID: 29428537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy.
    Yılmaz U; Ozdemir O; Batum O; Ermin S
    Indian J Cancer; 2018; 55(3):276-281. PubMed ID: 30693894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma.
    Yoshida K; Yoshikawa N; Shirakawa A; Niimi K; Suzuki S; Kajiyama H; Kikkawa F
    J Gynecol Oncol; 2019 Nov; 30(6):e85. PubMed ID: 31576683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
    Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
    Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Preoperative Platelet-to-Lymphocyte Ratio with Poor Outcome in Patients with Distal Cholangiocarcinoma.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Ogata Y
    Oncology; 2019; 96(6):290-298. PubMed ID: 30909286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic resonance imaging in categorization of ovarian epithelial cancer and survival analysis with focus on apparent diffusion coefficient value: correlation with Ki-67 expression and serum cancer antigen-125 level.
    Zhang G; Yao W; Sun T; Liu X; Zhang P; Jin J; Bai Y; Hua K; Zhang H
    J Ovarian Res; 2019 Jun; 12(1):59. PubMed ID: 31242916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Use of Platelet/Lymphocyte Ratio and Cancer Antigen 125 Combined with Magnetic Resonance Diffusion-Weighted Imaging in Diagnosis of Recurrent Ovarian Cancer and Neuropathic Pain.
    Wang N; Li C; Yang Y; Guan Y; Wang F; Wang Y; Zhao W
    World Neurosurg; 2021 May; 149():502-510. PubMed ID: 33326856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer.
    Lee M; Kim SW; Nam EJ; Yim GW; Kim S; Kim YT
    Gynecol Oncol; 2011 Aug; 122(2):238-41. PubMed ID: 21531448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.
    Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Cunningham D; Mudan S
    Med Oncol; 2014 Oct; 31(10):239. PubMed ID: 25218270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roles of neutrophil/lymphocyte and platelet/lymphocyte ratios in the early diagnosis of malignant ovarian masses.
    Yildirim MA; Seckin KD; Togrul C; Baser E; Karsli MF; Gungor T; Gulerman HC
    Asian Pac J Cancer Prev; 2014; 15(16):6881-5. PubMed ID: 25169540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
    Templeton AJ; Ace O; McNamara MG; Al-Mubarak M; Vera-Badillo FE; Hermanns T; Seruga B; Ocaña A; Tannock IF; Amir E
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1204-12. PubMed ID: 24793958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
    Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
    J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients.
    Messager M; Neofytou K; Chaudry MA; Allum WH
    Eur J Surg Oncol; 2015 Oct; 41(10):1316-23. PubMed ID: 26166786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
    Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
    World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion.
    Lim JU; Yeo CD; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
    Sci Rep; 2019 Mar; 9(1):4721. PubMed ID: 30886226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutrophil-to-Lymphocyte Ratio and Platelet Count Predict Long-Term Outcome of Stage IIIC Epithelial Ovarian Cancer.
    Zhou M; Li L; Wang X; Wang C; Wang D
    Cell Physiol Biochem; 2018; 46(1):178-186. PubMed ID: 29587273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study.
    Kim HS; Choi HY; Lee M; Suh DH; Kim K; No JH; Chung HH; Kim YB; Song YS
    Cancer Res Treat; 2016 Jan; 48(1):250-8. PubMed ID: 25761476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery.
    Yu J; Ding Z; Yang Y; Liu S
    Medicine (Baltimore); 2018 Jun; 97(25):e11002. PubMed ID: 29923983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.